<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a systemic, <z:hpo ids='HP_0011010'>chronic</z:hpo>, relapsing <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> of unknown etiology characterized by <z:e sem="disease" ids="C0554021" disease_type="Disease or Syndrome" abbrv="">recurrent oral aphthae</z:e>, <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulcerations</z:e> and <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The main pathological mechanism is leukocytoclastic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CLINICAL CASE: We present the case of a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease that presented as a relapsing <z:e sem="disease" ids="C0025309" disease_type="Disease or Syndrome" abbrv="">meningoencephalitis</z:e> with lymphocytic pleocytosis and high protein levels in cerebrospinal fluid </plain></SENT>
<SENT sid="3" pm="."><plain>The MRI revealed a lesion in the brain stem and part of diencephalon </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: The central <z:mp ids='MP_0008912'>nervous</z:mp> system is involved in up to 5%-20% of patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, this being the first manifestation in 3% of the cases </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical course includes: patients with an isolated episode with complete or incomplete recovery, relapsing and remitting forms, progressive forms or asymptomatic neurological involvement </plain></SENT>
<SENT sid="6" pm="."><plain>The most frequent presentation is relapsing <z:e sem="disease" ids="C0025309" disease_type="Disease or Syndrome" abbrv="">meningoencephalitis</z:e>, with progressive course localized in the brain stem </plain></SENT>
<SENT sid="7" pm="."><plain>Prognosis varies according to the type of neurologic process </plain></SENT>
<SENT sid="8" pm="."><plain>The worse outcome is in the parenchymal forms with brain stem and spinal cord involvement </plain></SENT>
<SENT sid="9" pm="."><plain>It also depends on the pathological findings in the cerebrospinal fluid, and the number of total events or recurrences after tapering the <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Mortality rate is high, up to 20% of cases after 7 years in patients with neurological involvement </plain></SENT>
</text></document>